Elizabeth R. Seaquist

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

Elizabeth R. Seaquist, John E. Anderson, Belinda P. Childs et al. · Diabetes Care · 2013 · 1.4K citations · Full text

Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline

Philip E. Cryer, Lloyd Axelrod, Ashley Grossman et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 1.2K citations · Full text

Familial Clustering of Diabetic Kidney Disease

Elizabeth R. Seaquist, Frederick C. Goetz, Stephen S. Rich et al. · New England Journal of Medicine · 1989 · 997 citations

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10